Metagenomi (MGX) Net Income towards Common Stockholders (2023 - 2025)
Historic Net Income towards Common Stockholders for Metagenomi (MGX) over the last 3 years, with Q3 2025 value amounting to -$20.4 million.
- Metagenomi's Net Income towards Common Stockholders fell 862.94% to -$20.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$88.7 million, marking a year-over-year decrease of 1999.08%. This contributed to the annual value of -$78.1 million for FY2024, which is 1436.23% down from last year.
- Metagenomi's Net Income towards Common Stockholders amounted to -$20.4 million in Q3 2025, which was down 862.94% from -$19.9 million recorded in Q2 2025.
- Metagenomi's Net Income towards Common Stockholders' 5-year high stood at -$10.7 million during Q2 2024, with a 5-year trough of -$25.1 million in Q1 2024.
- For the 3-year period, Metagenomi's Net Income towards Common Stockholders averaged around -$19.2 million, with its median value being -$19.8 million (2023).
- As far as peak fluctuations go, Metagenomi's Net Income towards Common Stockholders soared by 1744.31% in 2024, and later tumbled by 8538.04% in 2025.
- Metagenomi's Net Income towards Common Stockholders (Quarter) stood at -$19.3 million in 2023, then dropped by 21.27% to -$23.4 million in 2024, then grew by 12.84% to -$20.4 million in 2025.
- Its Net Income towards Common Stockholders was -$20.4 million in Q3 2025, compared to -$19.9 million in Q2 2025 and -$25.0 million in Q1 2025.